Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CureVac (CVAC) EPS (Basic) (2019 - 2025)

Historic EPS (Basic) for CureVac (CVAC) over the last 7 years, with Q3 2025 value amounting to $282587.6.

  • CureVac's EPS (Basic) rose 585.62% to $282587.6 in Q3 2025 from the same period last year, while for Sep 2025 it was $282587.6, marking a year-over-year increase of 585.62%. This contributed to the annual value of $6.02 for FY2024, which is 57451.74% up from last year.
  • According to the latest figures from Q3 2025, CureVac's EPS (Basic) is $282587.6, which was up 585.62% from -$2.23 recorded in Q2 2025.
  • Over the past 5 years, CureVac's EPS (Basic) peaked at $282587.6 during Q3 2025, and registered a low of -$223293.5 during Q1 2024.
  • Its 5-year average for EPS (Basic) is -$37441.9, with a median of -$64700.5 in 2021.
  • Per our database at Business Quant, CureVac's EPS (Basic) tumbled by 211663.18% in 2022 and then skyrocketed by 53332.29% in 2024.
  • CureVac's EPS (Basic) (Quarter) stood at -$0.25 in 2021, then tumbled by 2116.63% to -$5.49 in 2022, then skyrocketed by 41.2% to -$3.23 in 2023, then decreased by 17.14% to -$3.78 in 2024, then soared by 7476651.68% to $282587.6 in 2025.
  • Its last three reported values are $282587.6 in Q3 2025, -$2.23 for Q2 2025, and $226452.2 during Q1 2025.